U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    SENP3 SUMO specific peptidase 3 [ Homo sapiens (human) ]

    Gene ID: 26168, updated on 7-Jul-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    High SENP3 expression is associated with stomach neoplasms.

    SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.
    Wang M, Sang J, Ren Y, Liu K, Liu X, Zhang J, Wang H, Wang J, Orian A, Yang J, Yi J., Free PMC Article

    10/8/2016
    SENP3, which is increased in gastric cancer cells, potentiates the transcriptional activity of FOXC2 through de-SUMOylation, in favor of the induction of specific mesenchymal gene expression in gastric cancer metastasis.

    De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells.
    Ren YH, Liu KJ, Wang M, Yu YN, Yang K, Chen Q, Yu B, Wang W, Li QW, Wang J, Hou ZY, Fang JY, Yeh ET, Yang J, Yi J., Free PMC Article

    06/6/2015
    Evidence show that mTOR-mediated phosphorylation of SENP3 facilitates the interaction with NPM1, thereby promoting nucleolar targeting.

    mTOR signaling regulates nucleolar targeting of the SUMO-specific isopeptidase SENP3.
    Raman N, Nayak A, Muller S., Free PMC Article

    01/17/2015
    SENP3 is associated with MLL1/MLL2 complexes and catalyzes deSUMOylation of RbBP5.

    The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation.
    Nayak A, Viale-Bouroncle S, Morsczeck C, Muller S.

    10/4/2014
    ROS induced SENP3 redistribution from the nucleoli to the nucleoplasm.

    Overexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation.
    Sun Z, Hu S, Luo Q, Ye D, Hu D, Chen F., Free PMC Article

    03/8/2014
    In a novel adaptive pathway to extreme cell stress, dynamic changes in SENP3 stability and regulation of Drp1 SUMOylation are crucial determinants of cell fate.

    SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia.
    Guo C, Hildick KL, Luo J, Dearden L, Wilkinson KA, Henley JM., Free PMC Article

    08/10/2013
    The shift of HIF-1 transactivation by reactive oxidative species is correlated with and dependent on the biphasic redox sensing of SENP3 that leads to the differential SENP3/p300 interaction and the consequent fluctuation in the p300 SUMOylation status.

    The biphasic redox sensing of SENP3 accounts for the HIF-1 transcriptional activity shift by oxidative stress.
    Wang Y, Yang J, Yang K, Cang H, Huang XZ, Li H, Yi J., Free PMC Article

    11/3/2012
    These results suggest that SMT3IP1 is a new regulator of the p53-Mdm2 pathway.

    The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
    Nishida T, Yamada Y.

    05/7/2011
    Hsp90/SENP3 association protects SENP3 from CHIP-mediated ubiquitination and subsequent degradation, but this effect of Hsp90 requires the presence of CHIP.

    Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90.
    Yan S, Sun X, Xiang B, Cang H, Kang X, Chen Y, Li H, Shi G, Yeh ET, Wang B, Wang X, Yi J., Free PMC Article

    01/8/2011
    Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)

    Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
    Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators., Free PMC Article

    09/15/2010
    Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)

    Polymorphisms in innate immunity genes and risk of childhood leukemia.
    Han S, Lan Q, Park AK, Lee KM, Park SK, Ahn HS, Shin HY, Kang HJ, Koo HH, Seo JJ, Choi JE, Ahn YO, Chanock SJ, Kim H, Rothman N, Kang D., Free PMC Article

    06/30/2010
    SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress.

    SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress.
    Han Y, Huang C, Sun X, Xiang B, Wang M, Yeh ET, Chen Y, Li H, Shi G, Cang H, Sun Y, Wang J, Wang W, Gao F, Yi J., Free PMC Article

    05/31/2010
    Results demonstrate that SENP1 is the most efficient SUMO protease acting on Elk-1, and that SENP3 has little effect on Elk-1. SENP2 has an intermediate effect, but its ability to activate Elk-1 is independent from its SUMO-deconjugating activity.

    SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.
    Witty J, Aguilar-Martinez E, Sharrocks AD., Free PMC Article

    05/31/2010
    Observational study of gene-disease association. (HuGE Navigator)See all PubMed (4) articles

    Risk of meningioma and common variation in genes related to innate immunity.
    Rajaraman P, Brenner AV, Neta G, Pfeiffer R, Wang SS, Yeager M, Thomas G, Fine HA, Linet MS, Rothman N, Chanock SJ, Inskip PD.

    Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.
    Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR, Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M, Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C, Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Munroe PB, Day IN, Kivimaki M, Whittaker J, Humphries SE, Hingorani AD, ASCOT investigators, NORDIL investigators, BRIGHT Consortium.

    Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.
    Hosgood HD 3rd, Zhang L, Shen M, Berndt SI, Vermeulen R, Li G, Yin S, Yeager M, Yuenger J, Rothman N, Chanock S, Smith M, Lan Q.

    Common variation in genes related to innate immunity and risk of adult glioma.
    Rajaraman P, Brenner AV, Butler MA, Wang SS, Pfeiffer RM, Ruder AM, Linet MS, Yeager M, Wang Z, Orr N, Fine HA, Kwon D, Thomas G, Rothman N, Inskip PD, Chanock SJ.

    12/2/2009
    SENP3 is a redox sensor that regulates HIF-1 transcriptional activity under oxidative stress through the de-SUMOylation of p300

    SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation.
    Huang C, Han Y, Wang Y, Sun X, Yan S, Yeh ET, Chen Y, Cang H, Li H, Shi G, Cheng J, Tang X, Yi J., Free PMC Article

    01/21/2010
    Data describe a mitotic SUMO2/3 conjugation-deconjugation cycle of Borealin and further assign a regulatory function of RanBP2 and SENP3 in the mitotic SUMO pathway.

    RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin.
    Klein UR, Haindl M, Nigg EA, Muller S., Free PMC Article

    01/21/2010
    Nucleolar protein B23/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteases.

    Nucleolar protein B23/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteases.
    Yun C, Wang Y, Mukhopadhyay D, Backlund P, Kolli N, Yergey A, Wilkinson KD, Dasso M., Free PMC Article

    01/21/2010
    SMT3IP1 desumoylates nucleophosmin and might controls its physiological functions at both the nucleolus and other subcellular compartments.

    SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin.
    Nishida T, Yamada Y.

    01/21/2010
    These results define SENP3 as an essential factor for ribosome biogenesis and suggest that deconjugation of SUMO2 from NPM1 by SENP3 is critically involved in 28S rRNA maturation.

    The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing.
    Haindl M, Harasim T, Eick D, Muller S., Free PMC Article

    01/21/2010
    firstprevious page of 2 nextlast